PlainRecalls

Takeda Development Center Americas, Inc.

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Nov 21, 2018

Subscribe to new Takeda Development Center A… recalls (RSS)

Agency notice ledger

Federal filing book Takeda Development Center A… LIGHT-BOOK · SINGLE-AGENCY

#5,880 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #5,880 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT drugs
  • CATS 2 categories
  • LATEST Nov 21, 2018
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Takeda Development Center Americas, Inc. accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Takeda Development Center A… compares to 14,151 recalling firms

Takeda Development Center Americas, Inc. ranks 5,880th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Takeda Development Center A… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 5880th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Takeda Development Center A… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Takeda Development Center Americas, Inc. holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Nov 21, 2018

AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC, Rockville MD 20850 and Takeda Pharmaceuticals America, Inc. Deerfield, IL 60015. Active Ingredient made in Japan, encapsulated in the United States. NDC 64764-080-60
FDA Drug Moderate Oct 17, 2018

Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30

Takeda Development Center A… is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

Aaa Cosmetica, Sa de Cv 2 Abc Sales 1 Inc 2 Abrams Royal Pharamacy 2 Acme United, of Rocky Mount, North Carolina 2

Frequently Asked Questions

How many federal recall notices name Takeda Development Center A…? ▼
PlainRecalls indexes 2 distinct federal recall events naming Takeda Development Center Americas, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Takeda Development Center A… sit among other recalling firms? ▼
Takeda Development Center Americas, Inc. ranks #5,880 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Takeda Development Center A…'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Takeda Development Center A…'s filing book? ▼
Filings for Takeda Development Center Americas, Inc. span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Takeda Development Center Americas, Inc.: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Takeda Development Center Americas, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026